Anticancer Activities of Thiosemicarbazides/Thiosemicarbazones: A Review

dc.contributor.authorArora, Shefali
dc.contributor.authorAgarwal, Shilpi
dc.contributor.authorSinghal, Shailey
dc.date.accessioned2015-03-13T08:07:44Z
dc.date.available2015-03-13T08:07:44Z
dc.date.issued2014
dc.description.abstractThere have been tremendous development in the chemotherapy of cancer and researches are still developing new and more effective drugs to combat this disease. Thiosemicarbazides and thiosemicarbazone possess a wide range of biological applications. This key biological role is often related with their capability to inhibit the enzyme ribonucleotide reductase, similar to what is observed with potent anticancer drugs such as triapine and methisazone. Recent studies have revealed that thiosemicarbazones can inhibit topoisomerase II enzyme. This review discusses current advances of an emerging ‘new wave’ of thiosemicarbazide/thiosemicarbazone and their metal complexes as potent anticancer agents, mode of action and toxicity caused by them.en_US
dc.identifier.citationInternational Journal of Pharmacy and Pharmaceutical Sciences, Vol 6, Issue 9, 2014en_US
dc.identifier.issn0975-1491
dc.identifier.urihttp://hdl.handle.net/123456789/1903
dc.subjectMedical Scienceen_US
dc.titleAnticancer Activities of Thiosemicarbazides/Thiosemicarbazones: A Reviewen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
review.pdf
Size:
356.13 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
603 B
Format:
Item-specific license agreed upon to submission
Description:

Collections